BioMimetic Therapeutics, Inc. (BMTI)

[surf1944]

And at BioMimetic Therapeutics Inc (BMTI), there was insider buying on Friday, by CEO Samuel Eugene Lynch who bought 70,000 shares at a cost of $2.41 each, for a trade totaling $168,523. Before this latest buy, Lynch made one other buy in the past twelve months, purchasing $30,902 shares at a cost of $2.35 each. BioMimetic Therapeutics Inc is trading up about 5.3% on the day Monday. So far Lynch is in the green, up about 13.8% on their purchase based on today’s trading high of $2.74.

http://www.forbes.com/sites/dividendchannel/2012/04/02/monday-42-insider-buying-report-rxn-bmti/?partner=yahootix

http://www.insidercow.com/history/company.jsp?company=bmti&B1=Search!